- Embecta agreed to acquire Owen Mumford for up to GBP 150 million, including GBP 100 million in upfront cash and up to GBP 50 million tied to Aidaptus auto-injector net sales over three years after closing.
- Closing is expected in Embecta’s fiscal Q3 2026, subject to regulatory approvals and other closing conditions.
- Owen Mumford reported net revenue of GBP 69.4 million and generated about 80% of its revenue in the UK and the U.S.
- Embecta plans to fund the upfront purchase price through borrowings under its revolving credit facility.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Embecta Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603190630PRIMZONEFULLFEED9674869) on March 19, 2026, and is solely responsible for the information contained therein.
Comments